Diverse asthma treatment pipeline presents major investment opportunity – Pharmaceutical Processing


Pharmaceutical Processing

Diverse asthma treatment pipeline presents major investment opportunity
Pharmaceutical Processing
The active and diverse treatment pipeline for asthma boasts a striking level of innovation, with many first-in-class products representing significant investment opportunities, says business intelligence provider GBI Research. The company's latest

View full post on asthma – Google News

Diverse Asthma Treatment Pipeline Presents Major Investment Opportunity, says … – Drug Discovery & Development

Diverse Asthma Treatment Pipeline Presents Major Investment Opportunity, says
Drug Discovery & Development
The company's latest report* states that while asthma therapy development is dominated by small molecule compounds, with 156 products representing 67% of the pipeline, the research and development landscape has moved towards biologics on an …

View full post on asthma – Google News

Pediatric Asthma: An Opportunity In Payment Reform And Public Health – Health Affairs (blog)

Pediatric Asthma: An Opportunity In Payment Reform And Public Health
Health Affairs (blog)
Asthma affects 7 million children – more than 10 percent of kids in the U.S. – and is the most common chronic childhood disease. Yet even with high levels of insurance coverage, 46 percent of pediatric patients have uncontrolled asthma. There are

View full post on asthma – Google News

Boston Scientific’s Device To Relieve Severe Asthma: A Major Opportunity – Seeking Alpha

Boston Scientific's Device To Relieve Severe Asthma: A Major Opportunity
Seeking Alpha
Earlier in 2012 Boston Scientific's incoming CEO Michael Mahoney said about the Alair asthma treatment that it will be marketed in 20 countries and 200 sites by the end of the 2012. Mahoney predicted that the worldwide market for bronchial thermoplasty

View full post on asthma – Google News